Elevalue Laboratories
Private Company
Funding information not available
Overview
Elevalue Laboratories is a privately held, specialized analytical services provider dedicated to the cell and gene therapy (CGT) market. The company operates as a one-stop shop for CGT developers, offering comprehensive assay development, qualification, validation, and testing services designed to meet stringent regulatory requirements. Its value proposition centers on deep CGT-specific expertise, speed, and precision, aiming to de-risk and accelerate the analytical pathway for clients moving from concept to commercialization. As a service provider, its success is tied to the growth and regulatory complexity of the broader CGT industry.
Technology Platform
Integrated suite of analytical methodologies (Potency/Bioassays, Flow Cytometry, Cell-Based Assays, qPCR/dPCR, Ligand-Binding Assays & MSD) specialized for the characterization and regulatory testing of Cell and Gene Therapies.
Opportunities
Risk Factors
Competitive Landscape
Elevalue competes with large, full-service CROs (e.g., Labcorp, Charles River) that have dedicated CGT units, as well as other specialized analytical service providers focused on biologics and cell therapy. Its differentiation is its pure-play CGT focus, deep expertise in complex potency assays, and positioning as an end-to-end partner for the analytical regulatory pathway.